• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

综合多组学方法对早发性结直肠癌进行独特的分子特征分析和分类。

Integrated multi-omics approach to distinct molecular characterization and classification of early-onset colorectal cancer.

机构信息

Department of Environmental Genomics, Jiangsu Key Laboratory of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, Jiangsu 211166, China; Department of Biostatistics, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, Jiangsu 211166, China.

Department of Oncology, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu 210029, China.

出版信息

Cell Rep Med. 2023 Mar 21;4(3):100974. doi: 10.1016/j.xcrm.2023.100974. Epub 2023 Mar 14.

DOI:10.1016/j.xcrm.2023.100974
PMID:36921601
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10040411/
Abstract

Incidence of early-onset colorectal cancer (EOCRC), defined by a diagnosed age under 50 years, is increasing, but its heterogeneous etiologies that differ from general CRC remain undetermined. We initially characterize the genome, epigenome, transcriptome, and proteome of tumors from 79 patients in a Chinese CRC cohort. Data for an additional 126 EOCRC subjects are obtained from the International Cancer Genome Consortium Chinese cohort and The Cancer Genome Atlas European cohort. We observe that early-onset tumors have a high tumor mutation burden; increased DNA repair features by mutational signature 3 and multi-layer pathway enrichments; strong perturbations at effects of DNA methylation and somatic copy-number alteration on gene expression; and upregulated immune infiltration as hot tumors underlying immunophenotypes. Notably, LMTK3 exhibits ancestral mutation disparity, potentially being a functional modulator and biomarker that drives molecular alterations in EOCRC development and immunotherapies. This integrative omics study provides valuable knowledge for precision oncology of CRC.

摘要

早发性结直肠癌(EOCRC)的发病率正在上升,其定义为诊断年龄在 50 岁以下,但与一般结直肠癌不同的是,其病因具有异质性,目前仍未确定。我们最初对来自中国 CRC 队列的 79 名患者的肿瘤进行了基因组、表观基因组、转录组和蛋白质组分析。此外,我们还从国际癌症基因组联盟中国队列和癌症基因组图谱欧洲队列中获得了另外 126 名 EOCRC 患者的数据。我们观察到早发性肿瘤具有较高的肿瘤突变负担;通过突变特征 3 和多层次通路富集,增加了 DNA 修复特征;DNA 甲基化和体细胞拷贝数改变对基因表达的强烈干扰;以及上调的免疫浸润,表现为免疫表型下的热肿瘤。值得注意的是,LMTK3 表现出祖先突变差异,可能是一种功能性调节剂和生物标志物,驱动 EOCRC 发展和免疫治疗中的分子改变。这项综合组学研究为 CRC 的精准肿瘤学提供了有价值的知识。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/482d/10040411/5f57bf16b259/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/482d/10040411/ad70f24b5f40/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/482d/10040411/a3b2bce3e4a6/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/482d/10040411/97b9bcd199d1/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/482d/10040411/1ccc00109afe/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/482d/10040411/419bae70c737/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/482d/10040411/32ab9d5e55cb/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/482d/10040411/5f57bf16b259/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/482d/10040411/ad70f24b5f40/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/482d/10040411/a3b2bce3e4a6/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/482d/10040411/97b9bcd199d1/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/482d/10040411/1ccc00109afe/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/482d/10040411/419bae70c737/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/482d/10040411/32ab9d5e55cb/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/482d/10040411/5f57bf16b259/gr6.jpg

相似文献

1
Integrated multi-omics approach to distinct molecular characterization and classification of early-onset colorectal cancer.综合多组学方法对早发性结直肠癌进行独特的分子特征分析和分类。
Cell Rep Med. 2023 Mar 21;4(3):100974. doi: 10.1016/j.xcrm.2023.100974. Epub 2023 Mar 14.
2
Multi-omics cluster defines the subtypes of CRC with distinct prognosis and tumor microenvironment.多组学聚类定义了具有不同预后和肿瘤微环境的 CRC 亚型。
Eur J Med Res. 2024 Mar 28;29(1):207. doi: 10.1186/s40001-024-01805-8.
3
Identifying individualized prognostic signature and unraveling the molecular mechanism of recurrence in early-onset colorectal cancer.识别个体化预后特征并揭示早发性结直肠癌复发的分子机制。
Eur J Med Res. 2023 Nov 20;28(1):533. doi: 10.1186/s40001-023-01491-y.
4
A Transcriptome and Methylome Study Comparing Tissues of Early and Late Onset Colorectal Carcinoma.转录组和甲基组学研究比较早发性和晚发性结直肠癌组织。
Int J Mol Sci. 2022 Nov 17;23(22):14261. doi: 10.3390/ijms232214261.
5
[Multi-omics research progress in early-onset colorectal cancer].[早发性结直肠癌的多组学研究进展]
Zhonghua Wei Chang Wai Ke Za Zhi. 2024 May 25;27(5):447-451. doi: 10.3760/cma.j.cn441530-20240205-00058.
6
Sporadic early-onset colorectal cancer is a specific sub-type of cancer: a morphological, molecular and genetics study.散发性早发性结直肠癌是一种特定的癌症亚型:形态学、分子学和遗传学研究。
PLoS One. 2014 Aug 1;9(8):e103159. doi: 10.1371/journal.pone.0103159. eCollection 2014.
7
Precision medicine in colorectal cancer: Leveraging multi-omics, spatial omics, and artificial intelligence.结直肠癌的精准医学:利用多组学、空间组学和人工智能
Clin Chim Acta. 2024 Jun 1;559:119686. doi: 10.1016/j.cca.2024.119686. Epub 2024 Apr 23.
8
Clinicopathological and molecular characteristics of early-onset vs late-onset colorectal cancer according to tumor location.根据肿瘤位置分析早发性与晚发性结直肠癌的临床病理和分子特征。
Int J Clin Oncol. 2022 Apr;27(4):749-755. doi: 10.1007/s10147-021-02101-9. Epub 2022 Jan 26.
9
Distinct plasma molecular profiles between early-onset and late-onset colorectal cancer patients revealed by metabolic and lipidomic analyses.代谢组学和脂质组学分析揭示早发性和晚发性结直肠癌患者之间的血浆分子特征差异。
J Pharm Biomed Anal. 2024 Apr 15;241:115978. doi: 10.1016/j.jpba.2024.115978. Epub 2024 Jan 12.
10
Trends, clinicopathological features, surgical treatment patterns and prognoses of early-onset versus late-onset colorectal cancer: A retrospective cohort study on 34067 patients managed from 2000 to 2021 in a Chinese tertiary center.早发性与晚发性结直肠癌的趋势、临床病理特征、手术治疗模式和预后:一项回顾性队列研究,纳入了 2000 年至 2021 年在中国一家三级中心接受治疗的 34067 例患者。
Int J Surg. 2022 Aug;104:106780. doi: 10.1016/j.ijsu.2022.106780. Epub 2022 Jul 16.

引用本文的文献

1
Mitochondrial metabolic reprogramming in colorectal cancer: mechanisms of resistance and future clinical interventions.结直肠癌中的线粒体代谢重编程:耐药机制与未来临床干预措施
Cell Death Discov. 2025 Aug 9;11(1):375. doi: 10.1038/s41420-025-02670-y.
2
Extracellular Vesicles for Clinical Diagnostics: From Bulk Measurements to Single-Vesicle Analysis.用于临床诊断的细胞外囊泡:从整体测量到单囊泡分析
ACS Nano. 2025 Aug 12;19(31):28021-28109. doi: 10.1021/acsnano.5c00706. Epub 2025 Jul 28.
3
The Translational Research Program in Cancer Differences across Populations.

本文引用的文献

1
Genomic Differences by Race Emerge in Colorectal Cancer.结直肠癌中出现种族间的基因组差异。
Cancer Discov. 2021 Jun;11(6):OF1. doi: 10.1158/2159-8290.CD-NB2021-0330. Epub 2021 Apr 12.
2
Gut instinct: a call to study the biology of early-onset colorectal cancer disparities.肠道直觉:呼吁研究早发性结直肠癌差异的生物学。
Nat Rev Cancer. 2021 Jun;21(6):339-340. doi: 10.1038/s41568-021-00356-y.
3
Prospective evaluation of dietary and lifestyle pattern indices with risk of colorectal cancer in a cohort of younger women.前瞻性评估年轻女性队列中饮食和生活方式模式指数与结直肠癌风险的关系。
跨人群癌症差异的转化研究项目
Cancer Epidemiol Biomarkers Prev. 2025 Jun 27. doi: 10.1158/1055-9965.EPI-24-1711.
4
Research progress of colorectal cancer in genomic and transcriptomic at multi-level.结直肠癌在基因组和转录组多水平的研究进展
Front Genet. 2025 May 30;16:1533817. doi: 10.3389/fgene.2025.1533817. eCollection 2025.
5
Postoperative adjuvant chemotherapy in patients with stage II early onset colorectal cancer: exploration and discovery using real-world data and the SEER database.II期早发性结直肠癌患者的术后辅助化疗:利用真实世界数据和SEER数据库进行探索与发现
Front Oncol. 2025 May 30;15:1566569. doi: 10.3389/fonc.2025.1566569. eCollection 2025.
6
LMTK3 regulation of EV biogenesis and cargo sorting promotes tumour growth by reducing monocyte infiltration and driving pro-tumourigenic macrophage polarisation in breast cancer.LMTK3对细胞外囊泡生物发生和货物分选的调控通过减少单核细胞浸润和驱动乳腺癌中促肿瘤巨噬细胞极化来促进肿瘤生长。
Mol Cancer. 2025 May 23;24(1):149. doi: 10.1186/s12943-025-02346-2.
7
Integration of multi-omics data to unveil the molecular landscape and role of piRNAs in early-onset colorectal cancer.整合多组学数据以揭示piRNA在早发性结直肠癌中的分子格局及作用。
BMC Med. 2025 Apr 29;23(1):250. doi: 10.1186/s12916-025-04074-2.
8
Convergent Mechanisms in Virus-Induced Cancers: A Perspective on Classical Viruses, SARS-CoV-2, and AI-Driven Solutions.病毒诱导癌症中的趋同机制:关于经典病毒、SARS-CoV-2及人工智能驱动解决方案的观点
Infect Dis Rep. 2025 Apr 16;17(2):33. doi: 10.3390/idr17020033.
9
Circulating DNA methylation-based diagnostic, prognostic, and predictive biomarkers in colorectal cancer.基于循环DNA甲基化的结直肠癌诊断、预后及预测生物标志物
Sci Rep. 2025 Apr 19;15(1):13577. doi: 10.1038/s41598-025-95712-5.
10
Integrative genome-wide aberrant DNA methylation and transcriptome analysis identifies diagnostic markers for colorectal cancer.全基因组整合异常DNA甲基化和转录组分析确定了结直肠癌的诊断标志物。
Arch Toxicol. 2025 May;99(5):2179-2196. doi: 10.1007/s00204-025-03990-9. Epub 2025 Mar 10.
Ann Oncol. 2021 Jun;32(6):778-786. doi: 10.1016/j.annonc.2021.03.200. Epub 2021 Apr 1.
4
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
5
Targeting pan-essential genes in cancer: Challenges and opportunities.靶向癌症中的泛必需基因:挑战与机遇。
Cancer Cell. 2021 Apr 12;39(4):466-479. doi: 10.1016/j.ccell.2020.12.008. Epub 2021 Jan 14.
6
An Update on the Epidemiology, Molecular Characterization, Diagnosis, and Screening Strategies for Early-Onset Colorectal Cancer.早期结直肠癌的流行病学、分子特征、诊断和筛查策略的最新进展。
Gastroenterology. 2021 Mar;160(4):1041-1049. doi: 10.1053/j.gastro.2020.12.068. Epub 2021 Jan 5.
7
Metabolic Signatures of Healthy Lifestyle Patterns and Colorectal Cancer Risk in a European Cohort.欧洲队列中健康生活方式模式与结直肠癌风险的代谢特征
Clin Gastroenterol Hepatol. 2022 May;20(5):e1061-e1082. doi: 10.1016/j.cgh.2020.11.045. Epub 2020 Dec 29.
8
Rising incidence of early-onset colorectal cancer - a call to action.结直肠癌发病年轻化——行动的召唤。
Nat Rev Clin Oncol. 2021 Apr;18(4):230-243. doi: 10.1038/s41571-020-00445-1. Epub 2020 Nov 20.
9
Open Targets Platform: supporting systematic drug-target identification and prioritisation.Open Targets 平台:支持系统性药物靶点识别和优先级排序。
Nucleic Acids Res. 2021 Jan 8;49(D1):D1302-D1310. doi: 10.1093/nar/gkaa1027.
10
Immunosenescence: a key player in cancer development.免疫衰老:癌症发展中的关键因素。
J Hematol Oncol. 2020 Nov 10;13(1):151. doi: 10.1186/s13045-020-00986-z.